Search Results 1291-1300 of 20081 for Hepatitis C

1. Mayo researchers invented a new class of AI to improve cancer research and treatments - Mayo Clinic News Network

   Mayo Clinic Minute: What is hepatitis C? Related Articles. Mayo Clinic uses DNA screening to prevent life-threatening reactions during anesthesia (VIDEO).

2. A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma - Mayo Clinic

   (Hep C patients may be enrolled if other parameters precluding hepatic impairment are met. And they are not undergoing active therapy for hepatitis C. Human ...

3. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

   Participation eligibility · Documentation of HBsAg, hepatitis B surface antibody (HBsAb), hepatitis B core antibody (HBcAb), and hepatitis C virus (HCV) antibody ...

4. A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis - Mayo Clinic

   Hepatitis B or Hepatitis C. - Impaired cardiac function or clinically significant cardiac diseases - Patients with Child-Pugh Class B or C - Impairment of ...

5. Wilson's disease - Diagnosis and treatment - Mayo Clinic

   Diagnosing Wilson's disease can be hard because its symptoms are similar to those of other liver diseases, such as hepatitis. Symptoms also may appear ...

6. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

   Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Primary biliary... ... hepatitis, Alcoholic hepatitis ...

7. Sutimlimab-jome (intravenous route) - Side effects & uses - Mayo Clinic

   Other Medical Problems · Hepatitis B or C or · HIV infection or · Serious infections or · Systemic lupus erythematosus (SLE)—Use with caution. May make these ...

8. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

   Untreated chronic hepatitis B or chronic hepatitis B virus (HBV) carriers with HBV DNA > 500 IU/mL (or > 2500 copies/mL) or active hepatitis C at screening:.

9. Cohort of Patients With Fatty Liver Disease - Mayo Clinic

   History of hepatitis B or C virus (HBV, HCV) infections;; History of alcoholic liver disease or alcohol abuse;; Autoimmune hepatitis;; Alpha-1-antitrypsin ...

10. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    Has chronic hepatitis B virus (HBV) infection* or chronic hepatitis C virus (HCV) infection. * HBV immune participants (ie, being hepatitis B surface ...